Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.

Deng XZ, Liu MY, Shen CT, Song HJ, Wang J, Fan YB, Luo QY, Tang J, Wei XE, Qiu ZL.

Open source

DOI
10.3389/fonc.2026.1895987
Published
2026-09-30
Container
Front Oncol
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1895987,
  title = {Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.},
  author = {Deng XZ and  Liu MY and  Shen CT and  Song HJ and  Wang J and  Fan YB and  Luo QY and  Tang J and  Wei XE and  Qiu ZL.},
  year = {2026},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2026.1895987},
  url = {https://doi.org/10.3389/fonc.2026.1895987}
}

RIS

TY  - JOUR
TI  - Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.
AU  - Deng XZ
AU  -  Liu MY
AU  -  Shen CT
AU  -  Song HJ
AU  -  Wang J
AU  -  Fan YB
AU  -  Luo QY
AU  -  Tang J
AU  -  Wei XE
AU  -  Qiu ZL.
PY  - 2026
JO  - Front Oncol
DO  - 10.3389/fonc.2026.1895987
UR  - https://doi.org/10.3389/fonc.2026.1895987
ER  - 

APA

XZ, D., MY, L., CT, S., HJ, S., J, W., YB, F., QY, L., J, T., XE, W., & ZL., Q. (2026). Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.. Front Oncol. https://doi.org/10.3389/fonc.2026.1895987

Source records